The endocannabinoid anandamide prevents TH17 programming of activated T lymphocytes while preserving TH1 responses

IntroductionAnandamide (AEA) is an endocannabinoid that has recently been recognized as a regulator of various inflammatory diseases as well as cancer. While AEA was thought to predominantly engage cannabinoid (CB) receptors, recent findings suggest that, given its protective anti-inflammatory role...

Full description

Bibliographic Details
Main Authors: Anastasiia Kiprina, Tom Teichmann, Virna Margarita Martín Giménez, Wenqing Xu, Fiona Sailer, Maike Windbergs, Walter Manucha, Andreas Weigert, Ralf P. Brandes
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-12-01
Series:Frontiers in Pharmacology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2024.1528759/full